Benzinga | Mar 26, 2021 07:33AM EDT

HC Wainwright & Co. Maintains Buy on Co-Diagnostics, Lowers Price Target to $16

HC Wainwright & Co. analyst Yi Chen maintains Co-Diagnostics (NASDAQ:CODX) with a Buy and lowers the price target from $30 to $16.